LSRNW is not currently offering any funding, however, we are happy to assist you with collaborative funding applications – just email us at email@example.com.
This page is a list of current open calls that are for collaborative and translational funding. This page is regularly updated, so bookmark us and check back for the latest developments.
Cancer Research UK – Funding Opportunities **Overview**
This scheme supports collaborations between cancer researchers and scientists from engineering/physical science disciplines.
Cancer Immunology Project Awards catalyse research and build the UK’s research base in cancer immunology by funding immunologists from non-cancer fields
This scheme provides funding for biomarker assay development, validation and qualification where there is a clear line of sight to clinical implementation.
Supports interventional clinical trials of cancer treatment (including systemic treatment, radiotherapy and surgery) with the aim of improving outcome.
Programme Awards provide long-term support for broad, multidisciplinary research where the aim is to answer an interrelated set of questions.
Supports researchers at all stages to develop early, novel and outside-the-box ideas and collaborations to build and make progress in the ED&D field.
Funds long-term, integrated and renewable programmes of exceptional science to transform how and when early cancers and pre-cancerous states are diagnosed.
Deadline: 04.10.2022 Preliminary / 15.03.2023 Full
The Career Establishment Award supports new group leaders who have a salaried independent position to establish their own independent research group.
We can develop your new cancer treatments from preclinical development through to early phase patient trials.
We consider applicants that:
- Have a novel cancer agent needing preclinical and/or clinical development
- Have supporting in vivo efficacy data
- Are based at a UK academic institution or;
- Are a pharmaceutical or biotech company (UK or international)
- Have already been in touch with our Centre for Drug Development to discuss the suitability of their proposal
All technology areas are considered, including small molecule, biological and other therapeutics.
Examples of eligible projects include those requiring:
- Preclinical development, including biomarkers, assays, and formulation development prior to a phase 1 trial
- Phase 1 trials, including phase 1a and 1b, first-in-human and first-in-class
- Combinations of unregistered and registered agents
- Early phase 2 proof of principle trials
- Studies on unlicensed agents in active commercial development that are off the company’s critical path or repurposed novel agents
Apply for global health funding to reduce the risk of non-communicable diseases through implementation research. You must:
- be based at a UK research organisation eligible for UKRI funding
- work in partnership with co-investigators based in low or middle income countries (LMICs) where the work will take place.
Your research must:
- take a life course approach
- focus on people aged 10 to 24 in LMICs.
Up to £5,000,000 is available (subject to quality). We expect to fund several projects.
Apply for funding to improve the methods used by others in biomedical and health research.
Your project must focus on an area within MRC or NIHR’s remit.
You must be a researcher based at an organisation eligible for UKRI funding.
You must have a graduate degree, although we expect most applicants to have a PhD.
The full economic cost of your project can be up to £625,000. MRC and NIHR will fund 80% of the full economic cost.
This is an ongoing scheme. Application rounds open twice per year, closing in June and November.
The 2022/23 Call for Research Proposals from Future Leaders in Cardiovascular Research is now open. This new round of the joint funding scheme between the British Heart Foundation, the German Centre for Cardiovascular Research and the Dutch Heart Foundation will support collaborative research projects between mid-career investigators based in the UK, Germany and the Netherlands, with up to ≈€1.5m per award.
Deadline: 27.07.2022 at 11.00am
Innovate UK is investing up to £25 million in the best game-changing, and world leading ideas, designed for swift, successful commercialisation. Ideas need to be genuinely new and novel, not just disruptive within their sector.
Applications can come from any area of technology and be applied to any part of the economy such as, but not exclusively, net zero, the arts, design and media.
Deadline: 16.11.2022 at 13.00
NIHR has a call open across its HSDR, HTA and Public Health Programmes for research into the most effective forms of health communication and public health messaging to use during a period of infectious disease/pandemic. The scope is not limited to COVID-19 patients and studies should be relevant to any infectious disease health communication and public health messaging. Several broad themes have been described within the commissioning brief, with examples of particular areas of interest for research. All research proposals should address the potential impact on health inequalities and equity of access, and the research should be co-produced.
This call is also supported by the Public Health Research and Health Technology Assessment Programmes, and therefore proposals are also welcomed which sit within the remit of two/all of the participating programmes. Stage 1 deadlines in November (HTA and HDSR; PHR yet to be announced).
This step-changing funding programme will fund the future leaders of scientific and clinical research into brain tumours. Over 12 years, this award could provide the right researcher with up to £1.7 million in funding and the support needed to set up their own lab.
We have established this funding to support and encourage the future leaders of scientific research in the brain tumour field. We will identify excellent early stage academic and clinical researchers and provide support so they can establish themselves as leading researchers in our field.
EU Cancer Mission – Proposed Topics for Call 2022
- At the recent national information events promoting the EU Cancer Mission, the European Commission has shared draft topic ideas for the next round of call for proposals for research and innovation projects. The next update of the Horizon Europe Missions Work Programme 2021-2022 is expected soon and the following topics are planned for the prospective deadline in September 2022 (subject to change):
- HORIZON-MISS-2022-CANCER-01-01: Improving and upscaling primary prevention of cancer through implementation research (RIA; indicative budget €50 million; indicative project size: €3-8 million);
- HORIZON-MISS-2022-CANCER-01-02: Pragmatic clinical trials to optimise treatment for patients (RIA; indicative budget €60 million; indicative project size: €4-6 million);
- HORIZON-MISS-2022-CANCER-01-03: Strengthen Comprehensive Cancer Infrastructures (CSA; indicative budget €3 million);
- HORIZON-MISS-2022-CANCER-01-04: Towards the creation of a European Cancer Patient Digital Centre (CSA; indicative budget €3 million);
- HORIZON-MISS-2022-CANCER-01-05: Creation of national Mission Hubs supporting the Mission on Cancer (CSA; indicative budget €3 million).
- As a reminder, three topics under the Cancer Mission Call 2021 call are currently open for submission in April.
- UKRO also provides information and support for subscribers to engage with EU Missions. We have a factsheet, recently held a webinar on How to Mobilise for EU Missions In Horizon Europe which can be watched on our Portal and reported on the European Commission’s Info days about Missions, the recordings and presentation slides from those events are now available on their website. Please contact Keith (Sextonk@cardiff.ac.uk) if you plan to join/lead a consortium to take on these challenges.
CO-INVESTING IN BUSINESS RESEARCH, DEVELOPMENT, AND INNOVATION FOR SUSTAINABLE GROWTH
SMARTCymru supports Welsh businesses to develop, implement and commercialise new products, processes and services.
So far we have supported over 390 Welsh businesses to carry out over 540 projects, creating and building on their capability to innovate.
We can assist your business at every stage of your Innovation Journey, with a phased approach to supporting Research and Development activity;
- ‘Feasibility‘ – to investigate the viability of your innovative ideas
- ‘Industrial Research‘ – to undertake practical research to develop proof of concept
- ‘Experimental Development‘- to show the results of your research in operation
- ‘Exploitation‘ – to exploit your new product or process successfully
Support is delivered by a team of highly experienced Innovation Specialists who will provide advice on the options available, to make the most of your innovative ideas. Your Innovation Specialist will guide you through each stage of the application.
To get started you can contact the Business Wales Helpline on 03000 6 03000
Funding for the SMARTCymru project is provided by the European Regional Development Fund (ERDF).
Deadline: Apply Anytime
The new investigator grant is the ESRC’s main scheme for early career researchers (ECRs). It enables social scientists who have yet to lead a major research project to make the transition to being independent researchers. As they deliver their high quality, impactful research, principal investigators will gain experience of managing and leading projects and teams with the support of an experienced mentor.
Information sessions: virtual sessions and individual support to help ECRs develop applications to the scheme:
– Session 1: An introduction to the grant – Tuesday 24 May, 11 am – 12 pm
– Session 2: The application process – Wednesday 8 June, 11 am – 12 pm
– Session 3: Pitch to peers – Tuesday 28 June, 2 – 4 pm
To register, please email Elinor Shepley on the AHSS research development team: firstname.lastname@example.org.